In a revealing interview on Benzinga’s Cannabis Insider podcast, Miguel Martin, CEO of Aurora Cannabis Inc (NASDAQ:ACB), offered an in-depth look into the company’s remarkable journey and strategic milestones, particularly highlighting their significant achievements in the global medical cannabis sector.
Unprecedented Growth And Strategic Acquisitions
“We just announced earnings this morning and we were thrilled to have record earnings, fifth quarter being adjusted EBITDA positive,” Martin said, setting the tone for an optimistic future for Aurora. Under his leadership, the company has seen a notable 41% increase in international medical cannabis revenue and a significant reduction in losses from the previous year. This success is attributed to Aurora’s strategic positioning in the global market, focusing on medical cannabis with a strong emphasis on quality and patient care.